These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22621148)

  • 1. Sudden limb weakness.
    O'Brien B; Parsons MW; Anderson CS
    Med J Aust; 2012 May; 196(9):572-7. PubMed ID: 22621148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
    Campbell BC; Mitchell PJ; Yan B; Parsons MW; Christensen S; Churilov L; Dowling RJ; Dewey H; Brooks M; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Kleinig T; Scroop R; Chryssidis S; Barber A; Hope A; Moriarty M; McGuinness B; Wong AA; Coulthard A; Wijeratne T; Lee A; Jannes J; Leyden J; Phan TG; Chong W; Holt ME; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
    Int J Stroke; 2014 Jan; 9(1):126-32. PubMed ID: 24207098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment with intravenous recombinant tissue plasminogen activator in an acute stroke patient presenting with hemiballism.
    Bembenek JP; Bilik M; Członkowska A
    Funct Neurol; 2015; 30(1):71-2. PubMed ID: 26214030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can baseline magnetic resonance angiography (MRA) status become a foremost factor in selecting optimal acute stroke patients for recombinant tissue plasminogen activator (rt-PA) thrombolysis beyond 3 hours?
    Ma L; Gao PY; Lin Y; Xue J; Wang XC; Wang YJ; Wang YL; Liao XL; Liu ML; Cui SM; Yu L; Tong SJ; Huang YL; Zhou YM
    Neurol Res; 2009 May; 31(4):355-61. PubMed ID: 19508818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: pro.
    Schellinger PD; Fiebach JB
    Stroke; 2005 May; 36(5):1104-5. PubMed ID: 15790944
    [No Abstract]   [Full Text] [Related]  

  • 7. Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: con.
    Zivin JA
    Stroke; 2005 May; 36(5):1105-6. PubMed ID: 15790943
    [No Abstract]   [Full Text] [Related]  

  • 8. Candidates for thrombolytic treatment in acute ischaemic stroke--where are our patients in Hong Kong?
    Siu YC; Wong TW; Lau CC
    J Accid Emerg Med; 1999 Nov; 16(6):412-7. PubMed ID: 10572812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical reasoning: An 83-year-old woman with acute right-sided weakness and chest pressure.
    Curiale GG; Schindler JL
    Neurology; 2013 Jan; 80(1):e8-11. PubMed ID: 23267037
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.
    Leiva-Salinas C; Patrie JT; Xin W; Michel P; Jovin T; Wintermark M
    Stroke; 2016 Feb; 47(2):397-403. PubMed ID: 26696647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do not substitute: IV thrombolytic selection errors in acute stroke.
    Scott PA; Davis LA
    Stroke; 2001 Feb; 32(2):580-3. PubMed ID: 11157205
    [No Abstract]   [Full Text] [Related]  

  • 12. Routine 24-Hour Computed Tomography Brain Scan is not useful in stable patients Post Intravenous Tissue Plasminogen Activator.
    Guhwe M; Utley-Smith Q; Blessing R; Goldstein LB
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):540-2. PubMed ID: 26679069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes.
    Scott PA; Silbergleit R
    Ann Emerg Med; 2003 Nov; 42(5):611-8. PubMed ID: 14581912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reperfusion strategy for simultaneous ST-segment elevation myocardial infarction and acute ischemic stroke within a time window.
    González-Pacheco H; Méndez-Domínguez A; Vieyra-Herrera G; Azar-Manzur F; Meave-González A; Rodríguez-Zanella H; Martínez-Sánchez C
    Am J Emerg Med; 2014 Sep; 32(9):1157.e1-4. PubMed ID: 24703066
    [No Abstract]   [Full Text] [Related]  

  • 16. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features.
    Guillan M; Alonso-Canovas A; Gonzalez-Valcarcel J; Garcia Barragan N; Garcia Caldentey J; Hernandez-Medrano I; Defelipe-Mimbrera A; Sanchez-Gonzalez V; Terecoasa E; Alonso de Leciñana M; Masjuan J
    Cerebrovasc Dis; 2012; 34(2):115-20. PubMed ID: 22854315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid meningitis presenting with a stroke-like attack treated with recombinant tissue plasminogen activator: a case presentation.
    Akamatsu M; Maki F; Akiyama H; Hara D; Hoshino M; Hasegawa Y
    BMC Neurol; 2018 Sep; 18(1):139. PubMed ID: 30189853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy at systemic lupus onset with secondary antiphospholipid syndrome. A rare stroke experience.
    Loharia JJ; Alam JM; Abdelhadi HA; Marei TF
    Neurosciences (Riyadh); 2015 Jan; 20(1):55-60. PubMed ID: 25630783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread subcutaneous haematoma after thrombolytic therapy in stroke patients. Mild falls at stroke onset may be dangerous.
    Mirowska-Guzel D; Kobayashi A; Członkowska A
    Neurol Neurochir Pol; 2006; 40(6):536-8. PubMed ID: 17199181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes.
    Picanço MR; Christensen S; Campbell BC; Churilov L; Parsons MW; Desmond PM; Barber PA; Levi CR; Bladin CF; Donnan GA; Davis SM;
    Int J Stroke; 2014 Apr; 9(3):266-9. PubMed ID: 24256139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.